FindTrial
Sign In

Effect of remote management on comprehensive management of diabetes mellitus during the COVID-19 epidemic

Effect of remote management on comprehensive management of diabetes mellitus during the COVID-19 epidemic

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2000040366
Enrollment
Unknown
Registered
2020-11-28
Start date
2020-12-01
Completion date
Unknown
Last updated
2021-02-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

diabetes mellitus

Interventions

Group 2:mobile phone WeChat APP
Group 1:Nil

Sponsors

The Second Hospital of Jilin University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. In possession of smartphone and WeChat APP; 2. Fluent in spoken and written Chinese; 3. Completing valid questionnaires; 4. Signing the electronic informed consent; 5. In possession of blood glucose monitoring equipment; 6. Aged 18-70 years; 7. Compliance with diagnostic criteria for T2DM, issued by WHO in 1999; 8. On diet and/or oral antidiabetic agents and/or insulin, all on stable dose for the past 3 months.

Exclusion criteria

Exclusion criteria: 1. Pregnant women or women planning pregnancy; 2. Patients with severe complications of diabetes; 3. Patients with other severe medicine diseases; 4. Patients infected with COVID-19.

Design outcomes

Primary

MeasureTime frame
fasting blood glucose;postprandial blood glucose;blood presure;body mass index;time in range;—

Countries

China

Contacts

Public ContactChuan Zhang

The Second Hospital of Jilin University

wangs93@sina.com+86 13804315328

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026